Tuesday, November 26, 2013

Adverse Actions and Social Media: A Look in to the Trends

Pin It Now!
ePharma Summit 2014 sponsors Visible recently released the report Adverse Actions and Social Media.  In this report, the Visible team takes an in-depth look at one of the common problems many Pharma companies see with using social media - an abundance of adverse reports that have to be reported should patients begin discussing them on their social platforms.

What they found throughout their research - which included over 12,530 posts throughout social media across 24 brands - was that the four items needed to report an adverse event (the full name of the patient, the full name of the reporter of the adverse event, the medication they were on and the adverse event that took place) that less than 5% off the entire social population was reporting the side effects.  They found that 3.3% of these mentions were adverse effects.  How many met all of the criteria needed to report an adverse event to the FDA?  Download the report to find out.

Visible will be joining us February 10-12, 2014 in New York City for the ePharma Summit.  For more information on the program, look at the digital agenda.  Would you like meet Visible?  As a reader of this blog when you register to join us an mention code XP1906BLOG, you'll save $100 off the standard rate.*

Do the results of Visible's study surprise you?  What is the best way for this industry to approach questions about adverse events on social media knowing these results?
Post a Comment